Healthcare - Biotechnology - NASDAQ - US
$ 0.1311
-6.36 %
$ 24.5 M
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-102 M
OPERATING CASH FLOW
-29.1 M
INVESTING CASH FLOW
36.5 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Tonix Pharmaceuticals Holding Corp.
| Net Income | -117 M |
| Depreciation & Amortization | 4.29 M |
| Capital Expenditures | -7.9 M |
| Stock-Based Compensation | 9.28 M |
| Change in Working Capital | -35 K |
| Others | 4.52 M |
| Free Cash Flow | -110 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | (116.7) | (110.2) | (92.3) | (50.5) | (28.6) | (26.1) | (21.1) | (38.8) | (48.1) | (27.6) | (10.9) | (9.4) | (3.5) | 17.7 K | 30.9 K | 21.1 K |
| Depreciation & Amortization | 4.3 | 1.3 | 50 K | 27 K | 26 K | 54 K | 70 K | 0.2 | 0.2 | 36 K | 17 K | 14.3 K | 9.3 K | 0 | 0 | 0 |
| Deferred Income Tax | 0 | (14.5) | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 9.3 | 10.9 | 7.9 | 2.9 | 1.5 | 1.6 | 1.8 | 3.3 | 4.4 | 3.1 | 1.7 | 0.9 | 0.4 | 0 | 0 | 0 |
| Other Operating Activities | 1.1 | 14.5 | 3.0 | 1.4 | (0.2) | 1.6 | 1.5 | 0.1 | 3.1 | 0.6 | 51 K | 1.4 | 53.4 K | 0 | 0 | 0 |
| Change in Working Capital | 35 K | 2 K | 5.8 | (2.4) | 0.5 | 0.4 | 0.1 | (2.1) | 1.0 | 1.0 | 0.6 | 0.3 | 0.3 | 258 | 3 K | 2.43 K |
| Cash From Operations | (102.0) | (98.1) | (75.6) | (48.6) | (26.7) | (24.0) | (19.1) | (37.3) | (42.5) | (22.8) | (8.5) | (5.7) | (2.6) | 18 K | 27.9 K | 23.6 K |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | (7.9) | (48.1) | (35.3) | (8.6) | 17 K | 6 K | 5 K | 66 K | (0.2) | (0.3) | 15 K | 35.7 K | 2.76 K | 0 | 0 | 0 |
| Other Items | (21.2) | 0 | 0 | 0 | 0 | 0 | 7.2 | 16.7 | (23.9) | 73 K | 0 | 90 | 3.07 K | 0 | 0 | 0 |
| Cash From Investing Activities | (29.1) | (48.1) | (35.3) | (8.6) | 17 K | 6 K | 7.2 | 16.6 | (24.2) | (0.4) | 15 K | 35.8 K | 302 | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | (14.0) | (47.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 8.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.6 | 2.0 | 50 K | 0 | 0 |
| Dividends Paid | 0 | (6.7) | 0 | (0.5) | (2.5) | (3.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 22.6 | 40 K | 98 K | 15.0 | 9.6 | 14.1 | 14 K | 0 | 9 K | 53.2 | 14.7 | 106 | 0 | 1.3 | 0 | 0 |
| Cash From Financing Activities | 36.5 | 87.8 | 212.5 | 123.1 | 12.9 | 23.5 | 18.5 | 20.5 | 47.7 | 53.2 | 14.9 | 7.5 | 2.6 | 10 K | 0 | 50 K |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | (94.6) | (58.4) | 101.6 | 66.0 | (13.8) | (0.5) | 6.6 | (0.2) | (19.0) | 30.0 | 6.4 | 1.7 | 24.2 K | 7.98 K | 27.9 K | 26.4 K |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | (109.9) | (146.2) | (110.9) | (57.1) | (26.7) | (24.0) | (19.1) | (37.4) | (42.8) | (23.2) | (8.5) | (5.7) | (2.6) | 18 K | 27.9 K | 23.6 K |